ClearPoint Neuro stockholders re-elect eight directors, approve incentive plan

Ratification of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Cherry Bekaert LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2024. The votes were cast as follows: For Against Abstentions Broker Non-Votes 18,941,669 68,614 21,001 —

Approval of the Fifth Amended and Restated 2013 Incentive Compensation Plan. The stockholders approved the Company’s Fifth Amended and Restated 2013 Incentive Compensation Plan. The votes were cast as follows: For Against Abstentions Broker Non-Votes 11,045,314 699,499 443,386 6,843,085

Election of Directors. The following named persons were elected as directors of the Company to serve until the 2025 annual meeting of stockholders or until their successors have been duly elected and qualified or until their earlier death, resignation, disqualification or removal. The votes were cast as follows: Name For Withheld Broker Non-Votes Joseph M. Burnett 12,037,171 151,028 6,843,085 R. John Fletcher 11,734,172 454,027 6,843,085 Lynnette C. Fallon 11,780,550 407,649 6,843,085 Pascal E.R. Girin 11,771,794 416,405 6,843,085 B. Kristine Johnson 11,730,889 457,310 6,843,085 Matthew B. Klein 11,850,463 337,736 6,843,085 Linda M. Liau 11,716,020 472,179 6,843,085 Timothy T. Richards 11,625,429 562,770 6,843,085

Advisory approval of executive compensation. The stockholders, on an advisory basis, approved the compensation of the Company’s executives. The votes were cast as follows: For Against Abstentions Broker Non-Votes 11,126,888 629,515 431,796 6,843,085